Yu Wang, Jiayang Zou, Yue Wang, Jinyang Wang, Xiaoming Ji, Tianyun Zhang, Yun Chu, Rui Cui, Guoliang Zhang, Geming Shi, Yuming Wu, Yunxiao Kang
Alzheimer's disease (AD) is a common chronic progressive neurodegenerative disorder, and curative treatment has not been developed. The objective of this study was to investigate the potential effects of hydralazine (Hyd, a hypertension treatment drug) on the development process of AD and its mechanisms. We treated 6-month-old male APP/PS1 mice with Hyd for 5 weeks, measured changes in behavior and pathological status, and analyzed differences in gene expression by RNA sequencing. The results demonstrated that Hyd improved cognitive deficits and decreased amyloid beta protein deposition in the cortex and hippocampus, while RNA sequencing analysis suggested that the regulation of neuroinflammation and energy metabolism might play pivotal roles for Hyd's beneficial effects...
September 1, 2023: Neuropharmacology